Porphyrin platinum conjugates – new aims

Potential Application of Photosensitizers With High-Z Elements for Synergic Cancer Therapy

The presence of heavy elements in photosensitizers (PS) strongly influences their electronic and photophysical properties, and hence, conjugation of PS with a suitable element is regarded as a potential strategy to improve their photodynamic properties. Moreover, PS conjugated to metal ion or metal complex and heavy atoms such as halogen have attracted considerable attention as promising agents for multimodal or synergistic cancer therapy. These tetrapyrrole compounds depending on the type and nature of the inorganic elements have been explored for photodynamic therapy (PDT), chemotherapy, X-ray photon activation therapy (PAT), and radiotherapy. Particularly, the combination of metal-based PS and X-ray irradiation has been investigated as a promising novel approach for treating deep-seated tumors, which in the case of PDT is a major limitation due to low light penetration in tissue. This review will summarize the present status of evidence on the effect of insertion of metal or halogen on the photophysical properties of PS and the effectiveness of various metal and halogenated PS investigated for PDT, chemotherapy, and PAT as mono and/or combination therapy.

A promising anticancer drug: a photosensitizer based on the porphyrin skeleton

Photodynamic therapy (PDT) is a minimally invasive combination of treatments that treat tumors and other diseases by using photosensitizers, light and oxygen to produce cytotoxic reactive oxygen species (ROS) inducing tumor cell apoptosis. Photosensitizers are the key part of PDT for clinical application and experimental research, and most of them are porphyrin compounds at present. Due to their unique affinity for tumor tissues, porphyrins are not only excellent photosensitizers, but also good carriers to transport other active drugs into tumor tissues, which can exert synergistic anticancer effects of PDT and chemotherapy. This article reviews the clinical development of porphyrin photosensitizers and the research status of porphyrin containing bioactive groups. Finally, future perspectives and the current challenges of photosensitizers based on the porphyrin skeleton are discussed.

Novel photosensitizing properties of porphyrin–chrysin derivatives with antitumor activity in vitro

Photodynamic therapy is a promising cancer treatment with the advantages of low toxicity, high efficiency, and noninvasiveness. In this study, 23 novel porphyrin–chrysin derivatives are synthesized using alkyl carbon chains as bridges. We use human gastric cancer cells (MGC-803) and human cervical cancer cells to evaluate the in vitro antitumor activity of all the porphyrin–chrysin derivatives, with 5-fluorouracil (5-Fu) as a positive control. Several of the prepared compounds showed effective photodynamic killing effects, among which 5-hydroxy-2-phenyl-7-(2-(4-(10,15,20-tris(4-hydroxyphenyl)porphyrin-5-yl)phenoxy)ethoxy)-4 H-chromen-4-one shows the highest antiproliferation activity on human cervical cancer cells, with a half maximal inhibitory concentration of 26.51 ± 1.15 µM. Flow cytometry analysis showed that human cervical cancer cell apoptosis might be induced by G1 phase arrest.

A facile synthesis and application of protoporphyrin derivatives on reducing the tobacco specific N-nitroamines levels of smoke

Two protoporphyrin derivatives were prepared by a facile method using inexpensive hemin as starting material. They were added to cigarette filters to reduce the carcinogenic tobacco specific N-nitroamines (TSNAs), especially toward NNK (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone) and NNN (N-nitrosonornicotine) for environment protection and public health. The reduction level of TSNAs was reached to 37.6% from MSS, with greater reductions when more porphyrin was included in the filter. The decrease level for NNK by protoporphyrin derivatives is more effective than NNN. The interaction between protoporphyrin derivatives and TSNAs (NNK and NNN) were investigated by fluorescence spectra and UV-visible titration. The correlation coefficients were 0.978~0.997 and the binding constants was the scope from 1.26 × 103 to 4.04 × 104. The interaction mechanisms between protoporphyrin derivatives and, NNK and NNN are possibly the co-interaction of hydrogen bond binding and strong π–π stacking.

Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings. 12. New heteropentanuclear complexes carrying four exocyclic cis-platin-like functionalities as potential bimodal (PDT/cis-platin) anticancer agents

Heteropentanuclear porphyrazines having the formula [(PtCl2)4LM] where L = tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato dianion and M = Zn(II), Mg(II)(H2O), Pd(II), Cu(II) or Co(II) were characterized by elemental analyses, IR-UV-visible spectroscopy and electrochemistry and the data compared to new and previously published results for the corresponding homopentanuclear compound [(PtCl2)4LPt]. This latter species has four external N2(py)PtCl2 coordination sites which closely resemble cis-platin, (NH3)2PtCl2, the potent chemotherapeutic anticancer drug, and is able to act as a photosensitizer for the generation of (1)O2, the cytotoxic agent in photodynamic therapy (PDT). UV-visible spectra and half wave potentials for reduction of [(PtCl2)4LM], [(PtCl2)4LPt], the parallel series of mononuclear [LM] compounds and the pentanuclear [(PdCl2)4LM] compounds were examined in the nonaqueous solvents dimethyl sulfoxide, pyridine, and dimethylformamide. The complete set of available data indicate that external coordination of the PtCl2 and PdCl2 units significantly increases the level of the electron-deficiency of the entire molecular framework despite the fact that these groups are far away from the central porphyrazine π-ring system and have coordination sites nearly orthogonal to the plane of the macrocycle. The pentanuclear species [(M'Cl2)4LM] (M' = Pt(II), Pd(II)) undergo multiple one-electron transfers and exhibit an easier reducibility as compared to related electrode reactions of the parent compounds [LM] having the same central metal. Aggregation phenomena and reducibility of the porphyrazines to their monoanionic form (prevalently in DMF) are observed for some of the examined compounds and were analyzed and accurately taken into account. Quantum yields of (1)O2 (ΦΔ), of interest in PDT, were measured for [(PtCl2)4LM] with M = Zn(II), Mg(II)(H2O), or Pd(II) and the related macrocycles [(PdCl2)4LM] and [LM] in dimethylformamide (DMF) and/or DMF preacidified with HCl (DMF/HCl, [HCl]: 1-2 × 10(-4) M). Excellent ΦΔ values (0.5-0.6) which qualify the compounds as potent photosensitizers in PDT were obtained for the pentanuclear species having Zn(II) or Pd(II) as central metal ions. The [(PtCl2)4LZn] and [(PtCl2)4LPd] complexes are of special interest as potential bimodal anticancer agents because of the incorporated four cis-platin-like functionalities.

Synthesis of di-pyropheophorbide-a-platinum(II) complex and the in vitro cytotoxicity against TC-1 tumor cells

This report focuses on the conjugation of a chemotherapeutic drug and photodynamic therapy (PDT) agent with the intention of obtaining an optimal anticancer agent for use in combination cancer treatment. We have used pyropheophorbide-a (PPa) as a PDT agent, which was linked with ethylenediamine using carbodimide/N-hydroxysuccinicimide coupling reagents to obtain a resulting reactive amine group. Next, the free amine-bearing PPa and potassium tetrachloroplatinate (K2PtCl4) were reacted in aqueous solution to obtain PPa-cisplatin complex. Subsequently, the PPa-based platinum complex was characterized through several methods including NMR spectroscopy, mass spectrometer and UV absorption spectroscopy and its in vitro cytotoxicity and cellular uptake were evaluated on the TC-1 cancer cell line. The results indicated that the conjugate has a greater cytotoxic effect in the dark than cisplatin, even though its phototoxic effect was slightly lower than that of free photosensitizer; in addition, the cellular uptake of complex at 0.125 and 0.25 μM was higher than that of free photosensitizer.

Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings: 11 Photoactivity of a new Pt(II) pentanuclear macrocycle bearing four cisplatin-like functionalities and its related monoplatinated species

The pentanuclear PtII porphyrazine compound [(PtCl2)4LPt] (L = tetrakis-2,3-[5,6-di(2-pyridyl)pyrazino]porphyrazinato dianion), the mononuclear species [LPt] and the octacation [L′Pt]8+ (neutralized by I- ions; L′ = L octaquaternized at the pyridine N atoms) were synthesized and characterized by IR/UV-visible spectral measurements. 1H and 13C NMR spectral data on [(PtCl2)4 LPt] indicate that the four PtCl2 units are coordinated at the pyridine N atoms of the peripheral dipyridinopyrazine fragments ("py–py" coordination) and the largely prevalent conformational arrangement of the entire macrocycle, established to have the external N2(py)PtCl2 coordination sites all oriented on the same side with respect to the plane of the central porphyrazine framework, closely recalls that which was previously defined for the related PdII analog [(PdCl2)4LPd] . The currently investigated triad of PtII macrocycles, like the related PdII species, behave as photosensitizers for the generation of singlet oxygen, the cytotoxic agent active in photodynamic therapy (PDT). A bimodal anticancer potentiality is expressed by the pentaplatinated compound, [(PtCl2)4LPt] , which represents an unprecedented example of a multifunctional drug due to the presence of four contiguous cisplatin-like functionalities.

Development of the synthesis of the diamine complexes of covalent conjugates of platinum(II) with octacarboxy-substituted cobalt phthalocyanine

Ethylenediamine-N,N′-diacetic acid complexes of the covalent conjugates of octacarboxy-substituted cobalt phthalocyanine with one, two and three platinum atoms (3a–c) were synthesized and characterized by elemental analysis, electronic absorption, infrared and mass spectra data.

Preferential solvation and solvation shell composition of free base and protonated 5, 10, 15, 20-tetrakis(4-sulfonatophenyl)porphyrin in aqueous organic mixed solvents

The solvatochromic properties of the free base and the protonated 5, 10, 15, 20-tetrakis(4-sulfonatophenyl)porphyrin (TPPS) were studied in pure water, methanol, ethanol (protic solvents), dimethylsulfoxide, DMSO, (non-protic solvent), and their corresponding aqueous-organic binary mixed solvents. The correlation of the empirical solvent polarity scale (E(T)) values of TPPS with composition of the solvents was analyzed by the solvent exchange model of Bosch and Roses to clarify the preferential solvation of the probe dyes in the binary mixed solvents. The solvation shell composition and the synergistic effects in preferential solvation of the solute dyes were investigated in terms of both solvent-solvent and solute-solvent interactions and also, the local mole fraction of each solvent composition was calculated in cybotactic region of the probe. The effective mole fraction variation may provide significant physico-chemical insights in the microscopic and molecular level of interactions between TPPS species and the solvent components and therefore, can be used to interpret the solvent effect on kinetics and thermodynamics of TPPS. The obtained results from the preferential solvation and solvent-solvent interactions have been successfully applied to explain the variation of equilibrium behavior of protonation of TPPS occurring in aqueous organic mixed solvents of methanol, ethanol and DMSO.

Synthesis, Structural Characterization, and Cytotoxic Activity of Novel Paramagnetic Platinum Hematoporphyrin IX Complexes: Potent Antitumor Agents

Three novel stable Pt(III) complexes with distorted octahedral structure and (dz2)1 ground state have been obtained in the course of Pt(II)-hematoporphyrin IX ((7,12-bis(1-hydroxyethyl)-3,8,13,17-tetramethyl-21H-23H-porphyn-2,18-dipropionic acid), Hp) interaction in alkaline aqueous medium and aerobic conditions. A redox interaction also takes place together with the complexation process leading to the formation of Pt(III) species and organic radicals. The processes in the reaction system and the structure of the complexes formed cis-[Pt(III)(NH3)2(Hp−3H)(H2O)2]⋅H2O1, [Pt(III)(Hp−3H)(H2O)2]⋅H2O2, and [Pt((O,O)Hp−2H)Cl(H2O)3] 3, were studied by UV-Vis, IR, EPR and XPS spectra, thermal (TGS, DSC), potentiometric and magnetic methods. The newly synthesized complexes show promising cytotoxic activity comparable with that of cis-platin in in vitro tests against a panel of human leukemia cell lines. The observed cytotoxicity of the complex 2 against SKW-3 cells (KE-37 derivative) is due to induction of cell death through apoptosis.

A Convenient Synthesis of Haematoporphyrin Ester-Ethers under Ultrasound Irradiation

A convenient approach to the synthesis of haematoporphyrin ester-ethers from haemin under ultrasound irradiation has been developed. This method provides several advantages such as shorter reaction time, high yields and environmental friendliness.

Overcoming biochemical pharmacologic mechanisms of platinum resistance with a texaphyrin-platinum conjugate

In our effort to investigate further texaphyrin conjugation as a means of increasing delivery and accumulation of known anticancer platinum agents in cancer cells, we have continued our studies on the mode of action of a texaphyrin-platinum conjugate, particularly in cisplatin-resistant tumor cells that are characterized by several mechanisms of resistance, including reduced drug accumulation. Our results provide support for the proposal that intracellular platinum and Pt-DNA adduct levels were significantly increased using our conjugate relative to corresponding Pt controls. Moreover, no differences were found in cellular accumulation and Pt-DNA adduct formation between Pt sensitive and Pt resistant ovarian cells. As a result, resistance to the conjugate was lower than cisplatin in resistant cells. Based on these results we conclude that texaphyrin conjugation provides a promising strategy for overcoming biochemical pharmacologic mechanisms of resistance.

First electrogeneration of a platinum(IV) porphyrin: elucidation of the Pt(II/IV) and Pt(IV/II) oxidation-reduction processes in nonaqueous media

The first example for electrogeneration of a Pt(IV) porphyrin from its Pt(II) form is presented and the Pt(II/IV) and reverse Pt(IV/II) oxidation-reduction processes are elucidated by electrochemistry and thin-layer UV-visible spectroelectrochemistry. Three products, [(TPP˙(+))Pt(II)](+), [(TPP)Pt(IV)](2+) and [(TPP˙(+))Pt(IV)](3+), produced by electrooxidation of the Pt(II) porphyrin have been characterized by in situ spectroelectrochemistry and ESR measurements after controlled potential bulk electrolysis. The first definitive evidence for the electrochemical conversion of a Pt(iv) porphyrin to its Pt(II) form is also presented. The potential for this electroreduction is highly dependent upon the nature of the anion, ClO(4)(-) or Cl(-). A mechanism for the reversible conversion between Pt(II) and Pt(IV) tetraphenylporphyrins is proposed.

Gadolinium texaphyrin (Gd-Tex)-malonato-platinum conjugates: synthesis and comparison with carboplatin in normal and Pt-resistant cell lines

The synthesis of a new PEG-solubilized gadolinium texaphyrin (Gd-Tex) conjugate containing a malonate-Pt(NH(3))(2) moiety is described. The effect of the tumor localizing Gd-Tex macrocycle on platinum activity was evaluated in cell culture. The malonate moiety, analogous to that present in carboplatin, is expected to release an aquated Pt(NH(3))(2) species under physiological conditions. The half-life in phosphate-buffered saline was found to be ca. 3 days at room temperature, and the hydrolytic product released from the conjugate was collected and confirmed as Pt-based by flameless atomic absorption spectrophotometry. Anti-proliferative activity was tested using A549 human lung cancer and A2780 human ovarian cancer cell lines. In both cell lines, the activity of the Gd-Tex conjugate was found to be similar to that of carboplatin. Efficacy against a Pt-resistant ovarian cell line greater than that displayed by carboplatin was also observed.

Proton-Induced Cis−Trans Conversion of a Platinum(II) Center Coordinated by l-Cysteinatocobalt(III) Metalloligands

Treatment of LambdaL-[Co(L-cys-N,S)(en)2]+ (l-H2cys = L-cysteine) with [PtCl4]2- in water, followed by the addition of acid, gave an S-bridged CoIII2PtII trinuclear complex ([1]4+), which was reversibly converted to its deprotonated complex ([2]2+) in an aqueous solution. While [1]4+ formed only a trans isomer, [2]2+ existed as a mixture of trans and cis isomers. The selective formation of a cis isomer was achieved by treatment of [1]4+ or [2]2+ with phthalic acid in water, which afforded a unique CoIII4PtII2 hexanuclear complex ([3]4+). Complex [3]4+ was reverted back to [1]4+ by treatment with aqueous HCl, accompanied by the complete cis-to-trans conversion.